![]() |
市場調查報告書
商品編碼
2032538
整形外科生物材料市場報告:按材料、應用和地區分類(2026-2034 年)Orthopedic Biomaterials Market Report by Material Type, Application, and Region 2026-2034 |
||||||
2025年全球整形外科生物材料市場規模達214億美元。展望未來,IMARC Group預測,該市場從2026年到2034年將以8.16%的複合年成長率成長,到2034年達到443億美元。推動市場成長的主要因素包括人口老化、產品快速創新、醫療產業的顯著成長、各項政府政策的實施、以及廣泛的研發活動。
整形外科生物材料是用於整形外科手術中替代或修復受損骨骼和關節組織的物質。這些材料包括合成材料和天然材料,旨在模擬骨骼和關節組織的特性。常見的整形外科生物材料包括陶瓷、生物活性玻璃、聚合物、磷酸鈣水泥、金屬和複合材料。它們廣泛應用於關節重建置換手術,例如髖關節、膝關節和肩關節置換術術,以及骨折固定、脊椎移植、骨移植和軟組織修復。這些材料具有高強度、高延展性、高斷裂韌性、高硬度、耐腐蝕性、可塑性和良好的生物相容性。
全球人口老化以及由此導致的骨關節炎、骨質疏鬆症和骨折等各種肌肉骨骼疾病風險族群的增加,是推動市場成長的主要因素。這導致整形外科疾病和損傷(包括運動傷害、退化性關節疾病和創傷性骨折)的盛行率上升,進一步促進了市場成長。人們對整形外科疾病的認知不斷提高,以及先進治療方法的廣泛應用,也促進了市場成長。此外,先進生物材料的引入,提高了生物相容性、耐久性、機械強度以及與生物組織的整合性,從而提高了整形外科植入的成功率和耐久性,加速了市場成長。在整形外科中使用天然來源的可生物分解材料來促進組織再生和癒合,也促進了市場成長。此外,微創手術需求的不斷成長,以及其切口更小、恢復更快、疼痛更輕、住院時間更短等優勢,也對市場成長產生了積極影響。其他支持市場成長的因素包括消費者購買力的提高、積極的研發活動、對醫療保健基礎設施和服務投資的增加,以及政府鼓勵醫療保健專業人員和患者選擇整形外科生物材料和治療方法的各種措施。
The global orthopedic biomaterials market size reached USD 21.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 44.3 Billion by 2034, exhibiting a growth rate (CAGR) of 8.16% during 2026-2034. The rising geriatric population, rapid product innovations, significant growth in the healthcare industry, the implementation of various government initiatives, and extensive research and development (R&D) activities are some of the key factors driving the market.
Orthopedic biomaterials are substances used in orthopedic surgery to replace or repair damaged bone or joint tissues. They are either synthetic or natural and are designed to mimic the properties of bone and joint tissues. Ceramics and bioactive glasses, polymers, calcium phosphate cement, metal, and composites are some of the common types of materials. Orthopedic biomaterials are widely used for joint replacement surgeries, such as hip, knee, and shoulder replacements, fracture fixations, spinal implants, bone grafting, and soft tissue repair. They exhibit high strength, ductility, fracture toughness, hardness, corrosion resistance, formability, and biocompatibility.
The rising geriatric population across the globe prone to the risk of various musculoskeletal disorders, such as osteoarthritis, osteoporosis, and fractures is one of the key factors propelling the market growth. In line with this, the increasing prevalence of orthopedic conditions and injuries, such as sports injuries, degenerative joint diseases, and traumatic fractures, is favoring the market growth. Moreover, the growing awareness about orthopedic disorders and the availability of advanced treatment solutions is acting as another growth-inducing factor. Apart from this, the introduction of advanced biomaterials that offer enhanced biocompatibility, durability, mechanical strength, and integration with natural tissues, improving the success rates and longevity of orthopedic implants, is providing an impetus to the market growth. Additionally, the utilization of biodegradable materials that are derived from natural sources and are used in orthopedics to promote tissue regeneration and healing is contributing to the market growth. Furthermore, the increasing demand for minimally invasive (MI) surgeries due to their advantages, such as smaller incisions, faster recovery, reduced pain, and shorter hospital stays, is positively impacting the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, growing investments in healthcare infrastructure and services, and the implementation of various government initiatives that encourage healthcare providers and patients to opt for orthopedic biomaterials and procedures, are supporting the market growth.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for orthopedic biomaterials. Some of the factors driving the North America orthopedic biomaterials market included the rising geriatric population, various technological advancements, and growing expenditure capacities of consumers.
The report has also provided a comprehensive analysis of the competitive landscape in the global orthopedic biomaterials market. Detailed profiles of all major companies have been provided. Some of the companies covered include Arthrex Inc., Berkeley Advanced Biomaterials, CAM Bioceramics B.V., Collagen Matrix Inc., CoorsTek Inc., Evonik Industries AG (RAG-Stiftung), Exactech Inc., Globus Medical Inc., Invibio Ltd. (Victrex plc), Koninklijke DSM N.V., Medical Devices Business Services Inc., Stryker Corporation, Zimmer Biomet, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.